OIRA Conclusion of EO 12866 Regulatory Review

RIN: 1210-AB37         View EO 12866 Meetings	Received Date: 09/10/2025
Title: Improving Transparency into Pharmacy Benefit Manager Fee Disclosure
Agency/Subagency: DOL / EBSA	Stage: Proposed Rule
Concluded Action: Consistent with Change	Concluded Date: 01/09/2026
Legal Deadline: None	Economically Significant: Yes
Publication Date:	Unfunded Mandates: Private Sector
Major:	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Undetermined	Small Entities Affected:
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No